QUADRANT CAPITAL GROUP LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 174 filers reported holding ACCELERON PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$6,0000.0%37
-17.8%
0.00%0.0%
Q2 2021$6,000
-33.3%
45
-30.8%
0.00%0.0%
Q1 2021$9,000
+200.0%
65
+150.0%
0.00%0.0%
Q4 2020$3,000
+200.0%
26
+100.0%
0.00%
Q3 2020$1,0000.0%13
+62.5%
0.00%
Q2 2020$1,00080.0%0.00%
Q1 2020$08
+166.7%
0.00%
Q4 2019$0
-100.0%
3
-99.7%
0.00%
-100.0%
Q1 2019$46,0001,0080.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 42,030$3,777,0006.01%
Artal Group S.A. 1,500,000$134,805,0005.70%
GREAT POINT PARTNERS LLC 535,627$48,137,0005.03%
KINGDON CAPITAL MANAGEMENT, L.L.C. 211,038$18,966,0003.47%
Cormorant Asset Management, LP 825,000$74,143,0003.44%
Graticule Asia Macro Advisors LLC 48,700$4,377,0003.20%
Avoro Capital Advisors LLC 860,000$77,288,0002.61%
QVT Financial LP 120,264$10,808,0002.52%
Ikarian Capital, LLC 316,900$28,480,0002.14%
Avidity Partners Management LP 166,000$14,918,0002.06%
View complete list of ACCELERON PHARMA INC shareholders